Premixed Insulins (70/30, 50/50) Injectable bulk supplier for pharma manufacturers

Premixed Insulins (70/30, 50/50) Injectable U-100 Suppliers & Bulk Manufacturers

Available Forms: Vials, pens

Available Strengths: U-100

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

Category: Diabetes

Premixed insulins (70/30, 50/50) combine rapid-acting and intermediate-acting insulins, providing both prandial and basal blood sugar control. They offer convenience with fewer injections, improve glycemic stability, and simplify management for type 2 diabetes patients. Their predictable action helps reduce post-meal spikes and fasting hyperglycemia.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Premixed insulins (70/30, 50/50) are regulated in the EU and US as combination biological medicines. In the EU, brands like Mixtard and Humulin 70/30 are approved by EMA based on comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, the FDA has approved products like Humulin 70/30 and Novolin 70/30, supported by detailed clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require robust regulatory dossiers for approval and post-marketing safety. For expert support with pharmaceutical dossiers and compliance, visit PharmaTradz, your trusted partner in regulatory solutions.

Premixed Insulins (70/30, 50/50) Injectable — third party manufacturing & bulk supply

Premixed Insulins (70/30, 50/50) Injectable U-100 is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Premixed Insulins (70/30, 50/50) Injectable is supplied as Vials, pens — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Premixed Insulins (70/30, 50/50) Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Premixed Insulins (70/30, 50/50) Injecta... →

Back to Listing

Frequently Asked Questions

Premixed Insulins (70/30, 50/50) Injectable is listed as Vials, pens in U-100. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Premixed Insulins (70/30, 50/50) Injectable is referenced against Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.